A pharmaceutical company developing drugs for autoimmune/metabolic and neurological diseases, with a special focus on the needs of individuals with Down syndrome.
Dec 14, 2018
Pharmasum Therapeutics presented at DNB Healthcare conference, Venture Session READ MORE >>
Jun 22, 2018
Pharmasum Therapeutics featured in the Norwegian Biotechnology Association publication READ MORE >>
May 23, 2018
Meet Pharmasum Therapeutics at the annual BIO meeting, Boston, USA READ MORE >>